Characteristics | n = 27 | Percentage |
---|---|---|
Gender | ||
Male | 15 | 56% |
Female | 12 | 44% |
Primary tumour | ||
Right | 7 | 26% |
Left | 12 | 44% |
Rectum | 8 | 30% |
Primary tumour | ||
Resected | 11 | 41% |
In situ | 16 | 59% |
Metastases | ||
Only liver | 13 | 48% |
Lymph nodes | 12 | 44% |
Lung | 5 | 19% |
Peritoneal carcinosis | 2 | 7% |
Chemonaive | 27 | 100% |
RAS status | ||
Wild-type | 13 | 48% |
Mutated | 14 | 52% |
Pre-treatment CEA | Mean 279 | Range 2–2650 ng/ml |
Evaluation CEA | Mean 77 | Range 2–899 ng/ml |
Median age | 64 | Range 45–84 years |
Treatment | ||
CAPOX | 4 | 15% |
Bev-CAPOX | 16 | 59% |
FOLFIRI | 1 | 4% |
Cet-FOLFIRI | 3 | 11% |
Pan-FOLPOX | 3 | 11% |